The recovering Japanese market, the implementation of the NHIS policy in South Korea, and growing awareness and income in China and Australia are all set to push the dental implant market forward.
Vancouver, BC (PRWEB) March 20, 2015
According to a recently published report series by iData Research (http://www.idataresearch.com), forecasts shows that the underutilized dental implant market in China will significantly contribute to Asia-Pacific market growth due to the influence of training programs, growing awareness and a rising national income. The final abutment market will grow at higher rates as a result of the more expensive and innovative CAD/CAM abutment products acquiring market share from relatively cheap stock abutments.
“The recovering Japanese market, the implementation of the NHIS policy in South Korea, and growing awareness and income in China and Australia are all set to push the dental implant market forward,” explains Dr. Kamran Zamanian, CEO of iData. “Annual growth surpassing 10% is anticipated in coming years.”
Other key findings from the 2015 iData Research report series entitled Asia-Pacific Markets for Dental Implants and Final Abutments:
Japan
Japan represents the second largest market for dental implants in the Asia-Pacific region. Despite selling fewer units than the market leader, South Korea, Japan is almost at par in terms of market value. The Japanese dental implant market mostly consists of premium-priced products.
South Korea
South Korea represents the majority of the dental implant and final abutment market in the Asia-Pacific region. As this country is home to a large number of globally leading dental implant companies, consumer awareness of dental implant procedures is relatively high.
Australia
Premium implant companies have dominated the Australian market for years. However, growing cost sensitivity and openness to discounted implant brands are set to shift the market. The premium segment of the market will grow far slower relative to the value and discount implant segments, resulting in declining ASPs.
China
The Chinese market for dental implants is the most underdeveloped and offers the greatest potential for growth. The growing national income and an influx of implant training programs have led to growing awareness.
Leading Competitors
Osstem Implants leads the Asia-Pacific dental implant market. It is expected that increased cost sensitivity in the overall market is set to increase Osstem’s market share, especially in regions where their low-cost implants have recently been introduced. Osstem Implant is expected to gain share in all four regions: Japan, South Korean, Australia, and China.
Other notable competitors in the Asia-Pacific markets for dental implants and final abutments include DENTSPLY Implants, Straumann, and Nobel Biocare.
For Further Information
More on the markets for dental implants and final abutments in South Korea can be found in the 2015 edition report by iData entitled Asia-Pacific Markets for Dental Implants and Final Abutments. This report series covers South Korea, Japan, Australia, and China, and includes sub-segments by country, and detailed market and unit share analysis.
The full iData series on the market for dental implants and final abutments also covers the U.S., Mexico, Brazil, Argentina, India, China, Canada, and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment.
Register online or email us at info(at)idataresearch(dot)net for an Asia-Pacific Markets for Dental Implants and Final Abutments report brochure and synopsis.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.